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Abstract
The 59-cap structure is a distinct feature of eukaryotic mRNAs, and eukaryotic viruses generally modify the 59-end of viral
RNAs to mimic cellular mRNA structure, which is important for RNA stability, protein translation and viral immune escape.
SARS coronavirus (SARS-CoV) encodes two S-adenosyl-L-methionine (SAM)-dependent methyltransferases (MTase) which
sequentially methylate the RNA cap at guanosine-N7 and ribose 29-O positions, catalyzed by nsp14 N7-MTase and nsp16 29-
O-MTase, respectively. A unique feature for SARS-CoV is that nsp16 requires non-structural protein nsp10 as a stimulatory
factor to execute its MTase activity. Here we report the biochemical characterization of SARS-CoV 29-O-MTase and the crystal
structure of nsp16/nsp10 complex bound with methyl donor SAM. We found that SARS-CoV nsp16 MTase methylated
m7GpppA-RNA but not m7GpppG-RNA, which is in contrast with nsp14 MTase that functions in a sequence-independent
manner. We demonstrated that nsp10 is required for nsp16 to bind both m7GpppA-RNA substrate and SAM cofactor.
Structural analysis revealed that nsp16 possesses the canonical scaffold of MTase and associates with nsp10 at 1:1 ratio. The
structure of the nsp16/nsp10 interaction interface shows that nsp10 may stabilize the SAM-binding pocket and extend the
substrate RNA-binding groove of nsp16, consistent with the findings in biochemical assays. These results suggest that
nsp16/nsp10 interface may represent a better drug target than the viral MTase active site for developing highly specific anti-
coronavirus drugs.
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Introduction
Coronaviruses are etiological agents of respiratory and enteric
diseases in livestock, companion animals and humans, exemplified
by severe acute respiratory syndrome coronavirus (SARS-CoV)
which was responsible for a worldwide SARS outbreak in 2003
and caused over 8000 cases of infection with about 10% fatality
rate. They are characterized by possessing the largest and most
complex positive-stranded RNA genome (ranging from 27 to
31 kb) among RNA viruses. Fourteen open reading frames (ORFs)
have been identified in the genome of SARS-CoV, of which 12 are
located in the 39-one third of the genome, encoding the structural
and accessory proteins translated through a nested set of
subgenomic RNAs [1,2]. The 59-proximal two thirds of the
genome comprise 2 large overlapping ORFs (1a and 1b), which
encode two large replicase polyproteins that are translated directly
from the genome RNA, with 1b as the frameshifted extension of
1a. These two precursor polyproteins are cleaved into 16 mature
replicase proteins, named as non-structural protein (nsp) 1–16,
which form the replication-transcription complex (RTC) localized
in endoplasmic reticulum-derived membranes [3,4]. Strikingly, the
coronavirus genome is predicted to encode several RNA
processing enzymes that are not common to small RNA viruses
[1], including nsp14 as an exoribonuclease and guanine N7-
methyltransferase (N7-MTase) [5,6,7,8] and nsp15 as a nidovirus-
specific endonuclease [9,10].
Eukaryotic and most viral mRNAs possess a 59-terminal cap
structure, in which an N7-methyl-guanine moiety is linked to the
first transcribed nucleotide by a 59-59 triphosphate bridge [11,12].
The cap structure is essential for efficient splicing, nuclear export,
translation and stability of eukaryotic mRNA [13,14,15,16]. All
viruses use the translational machinery of host cells. With the
exception of some viruses, such as picornaviruses and hepatitis C
virus that circumvent the capping problem by using an internal
ribosome entry site (IRES) for mRNA translation [17,18], viruses
of eukaryotes have evolved diversified strategies to cap their
mRNAs that are thus translated by cap-dependent mechanisms in
the manner of eukaryotic mRNAs. It has been suggested for three
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[19,20,21,22], but the principal enzymes involved in coronavirus
RNA capping and their biochemical mechanisms have not been
characterized until recently. Cap formation of eukaryotic and viral
mRNAs requires universally three sequential enzymatic reactions.
First, an RNA triphosphatase (TPase) removes the c-phosphate
group from the 59-triphosphate end (pppN) of the nascent mRNA
chain to generate the diphosphate 59 -ppN. Subsequently, a RNA
guanylyltransferase (GTase) transfers a GMP to the 59-diphos-
phate end to yield the cap core structure (GpppN). Then a N7-
MTase methylates the capping guanylate at the N7 position to
produce a cap-0 structure (m7GpppN) [13]. While lower
eukaryotes, including yeast, employ a cap-0 structure, higher
eukaryotes and viruses usually further methylate the cap-0
structure at the ribose 29-O position of the first and second
nucleotide of the mRNA by a ribose 29-O MTase to form cap-1
and cap-2 structure, respectively [13]. Very recently, it was shown
that ribose 29-O-methylation of viral RNA cap provides a
mechanism for viruses to escape host immune recognition [23,24].
For coronaviruses, several nsps have been indicated to be
involved in viral RNA capping. We have shown that SARS-CoV
nsp14, a previously described exoribonuclease, acts as N7-MTase
to generate cap-0 structure [8]. Recently, it was shown that SARS-
CoV nsp16 acts as 29-O-MTase in complex with nsp10 and
selectively 29-O-methylates the cap-0 structure to give rise to cap-1
structure [25]. Feline coronavirus (FCoV) nsp16 was also shown to
bind N7-methyl guanosine cap (m
7GpppAC3-6) and methylate the
penultimate nucleotide at 29-O position to yield a cap-1 structure
in vitro [26]. Coronavirus nsp13 has been shown to exhibit RNA
TPase activity in vitro and thus proposed to be functional in RNA
capping reaction [27,28], but a direct role for nsp13 in RNA
capping still awaits experimental evidence. Currently, the RNA
GTase that is essential for cap formation is completely unknown
for coronaviruses.
SARS-CoV nsp16 requires nsp10 as a stimulatory factor to
execute its 29-O-MTase activity [25] and this also holds true for
other coronaviruses (our unpublished results). This mechanism is
unique for 29-O-MTase of coronaviruses and has not been found
in any other viruses or host cells. However, the molecular
mechanisms underlying the enzymatic activity of nsp16 and the
stimulatory effect of nsp10 are unknown. Here we report the
crystal structure of the heterodimer of nsp16 and nsp10 (nsp16/
nsp10) with bound methyl donor SAM and biochemical
characterization of the stimulation mechanisms. We found that
nsp10 is required for nsp16 to bind both SAM and RNA substrate,
and the crystal structure shows that nsp10 may stabilize the SAM-
binding pocket and extend the RNA-binding groove of nsp16.
These results have implications for designing specific anti-
coronavirus drugs to control infection.
Results
Specific 29-O-methylation of GpppA-capped RNA by
SARS-CoV nsp14/nsp16/nsp10 complex
In our previous work, we adopted a genetic screening system and
biochemical assays to identify SARS-CoV nsp14 as N7-MTase [8].
However, we did not observe any 29-O-MTase activity in various
biochemical assays for SARS-CoV nsp16, which was previously
predicted to be 29-O-MTase [1,29], although a low 29-O-MTase
activitywasdemonstrated forfelinecoronavirusnsp16[26].Weand
othersshowedpreviouslythat SARS-CoV nsp10could interact with
both nsp14 and nsp16 [30,31], suggesting a role for nsp10 in the
functions of nsp14 and nsp16. Therefore, we undertook to test the
effectsof nsp10 on the MTase activitiesof both nsp14 and nsp16. As
shown in Figure 1A, by using radiolabeled and unmethylated
G*pppA-capped RNA as substrate (where the * indicates that the
following phosphate was
32P labeled, and the sequence is identical
with viral genomic RNA except for the second nucleotide), nsp14
alone could efficiently N7-methylate GpppA-RNA to generate cap-
0 structure (m7GpppA) (Figure 1A, lane 2) and nsp10 did not
significantly alter nsp14 N7-MTase activity in our testing system
(Figure 1A, lane 4). While either nsp16 or nsp10 alone did not show
any MTase activity (Figure 1A, lanes 3 and 1), the mixture of
nsp10/nsp14/nsp16 gave rise to cap-1 structure (m7GpppAm)
(Figure 1A, lane 7), indicating that addition of nsp10 and nsp16
rendered the complex active in the 29-O-MTase reaction. We then
used radiolabeled m7G*pppA-capped RNA substrate and demon-
strated that nsp14 could not 29-O-methylate RNA cap-0 structure
(Figure 1A, lane 12) but the mixture of nsp16 and nsp10 (nsp16/
nsp10) did possess the 29-O-MTase activity to convert cap-0 to cap-
1 structure at pH 7.5 and 8.0 (Figure 1A, lanes 10 and 16). These
results indicate that nsp10 may function as a stimulatory factor for
nsp16 and is required for the 29-O-MTase activity of nsp16. While
this work was ongoing, similar observations were made by Bouvet
et al. [25].
Our previous studies showed that SARS-CoV nsp14 N7-MTase
could N7-methylate both GpppA- and GpppG- capped RNA in a
sequence-independent manner [8]. As both the genomic and
subgenomic RNAs of SARS-CoV all start with an adenine, we
tested whether SARS-CoV nsp16 29-O-MTase has sequence
specificity by using m7GpppA- and m7GpppG-capped RNAs as
substrates. As shown in Figures 1B and 1C, SARS-CoV nsp16/
nsp10 complex gave a strong methylation signal on m7GpppA-
capped RNA substrate but not on m7GpppG-capped RNA,
suggesting that SARS-CoV nsp16/nsp10 functions in cap
sequence-specific manner. The VP39 29-O-MTase of vaccinia
virus was used as a control in the methylation assay system
(Figure 1C). Furthermore, we observed that nsp16/nsp10 could
not methylate cap analogues and individual NTPs (Figure 1B),
indicating that the RNA substrate for nsp16/nsp10 needs to
contain a stretch of nucleotides linked to the cap. A recent study
Author Summary
The distinctive feature of eukaryotic mRNAs is the
presence of methylated cap structure that is required for
mRNA stability and protein translation. As all viruses
employ cellular ribosomes for protein translation, most
cytoplasmically replicating eukaryotic viruses including
coronaviruses have evolved strategies to cap their RNAs.
It was shown very recently that ribose 29-O-methylation in
the cap structure of viral RNAs plays an important role in
viral escape from innate immune recognition. The 29-O-
methyltransferase (29-O-MTase) encoded by SARS corona-
virus is composed of two subunits, the catalytic subunit
nsp16 and the stimulatory subunit nsp10, which is
different from all other known 29-O-MTases that are
partner-independent. Here we show that the role of
nsp10 is to promote nsp16 to bind capped RNA substrate
and the methyl donor S-adenosyl-L-methionine (SAM). We
solved the crystal structure of the nsp16/nsp10/SAM
complex, and the structural analysis revealed that the
details of the inter-molecular interactions and indicated
that nsp10 may stabilize the SAM-binding pocket and
extend the capped RNA-binding groove. The interaction
interface of nsp16/nsp10 is unique for coronaviruses and
thus may provide an attractive target for developing
specific antiviral drugs for control of coronaviruses
including the deadly SARS coronavirus.
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substrate for nsp16 [25]. In this short RNA substrate, only the first
nucleotide is identical with the first nucleotide A in the SARS-CoV
genome RNA and the remaining 4 nucleotides are different from
the genomic sequence. Taken together, these results indicate that
the first nucleotide A is the sequence determinant for nsp16
methylation specificity. These results also suggest that nsp16 or
nsp16/nsp10 complex need to form an RNA-binding groove that
has enough space and affinity to accommodate m7GpppA-capped
RNA with an extension of a few of nucleotides. Binding of the
cofactor SAM and substrate RNA to MTase is the prerequisite for
its enzymatic activity, and therefore we next tested whether SARS-
CoV nsp10 might promote the SAM- and RNA-binding capability
of nsp16.
Nsp10 promotes the binding of the cofactor SAM to
nsp16
SAM is the methyl donor for both N7- and 29-O-MTase in
RNA cap methylation, and high affinity binding and correct
positioning of the cofactor in the SAM-binding site of the MTase
provides the basis for the methyl transfer into the substrate RNA.
Therefore, we first tested whether nsp10 could influence the
binding affinity of nsp16 toward SAM. As shown in Figure 2A,
nsp16 alone or the complex of nsp10 and control proteins (nsp12N
and nsp3-SUD) were not able to bind SAM at different pH values
(Figure 2A, lanes 1, 2, 6, and 7). However, nsp16 could bind SAM
when complexed with nsp10 (Figure 2A, lanes 3 and 4). In the
mixture nsp10/nsp14/nsp16, both nsp14 and nsp16 could bind to
SAM (Figure 2A, lane 5). There were no signals at the position of
nsp10 in SAM binding assays (data not shown). These results
demonstrate that nsp10 could boost nsp16 to bind the methyl
donor SAM.
To further study the different SAM binding affinity of SARS-
CoV nsp16/nsp10 complex and nsp16 or nsp10 alone, isothermal
titration calorimetry (ITC) was used to measure the thermody-
namic changes during SAM-binding. ITC profiles for the binding
of SAM to nsp16, nsp10 and nsp16/nsp10 complex (Figures 2B,
2C and 2D, respectively) of SARS-CoV showed that the complex
of SARS-CoV nsp16 and nsp10 could bind SAM specifically but
either nsp16 or nsp10 alone could not. The top panels in
Figures 2B-D show raw ITC curves resulting from the injections of
SAM into a solution of nsp16 (Figure 2B), nsp10 (Figure 2C), and
nsp16/nsp10 complex of SARS-CoV (Figure 2D). The titration
curves show that SAM binding to nsp16/nsp10 complex is
exothermic, resulting in negative peaks in the plots of power versus
time (Figure 2D). However, adding SAM to either nsp16 or nsp10
Figure 1. Biochemical analyses of the MTase activities of SARS-
CoV nsp14, nsp16 and nsp10. (A) TLC analysis of nuclease P1-
resistant cap structures released from
32P-labeled G*pppA-RNA
methylated by nsp10, nsp14, nsp16, nsp14/nsp10, nsp16/nsp10,
nsp14/nsp16, and nsp10/nsp14/nsp16, respectively (lanes 1–7), and
m7G*pppA-RNA methylated by nsp16/nsp10 (at pH 7.5), nsp10, nsp14,
nsp16, nsp14/nsp10, nsp10/nsp14/nsp16, nsp16/nsp10, and nsp14/
nsp16, respectively (at pH 8.0) (lanes 10–17). The markers G*pppA (lane
8), m7G*pppA (lane 9), and m7G*pppAm (lane 18) were prepared with
commercial vaccinia virus capping enzymes. The positions of origin and
migration of G*pppA, m7G*pppA, and m7G*pppAm (lanes 8, 9, and 18)
are indicated on the left. The bands located between origin and
G*pppA are free a-
32P-GTP, which may be left over after one-step
purification of labeled RNA. (B) Different RNA substrates were used to
test the methylation activities of nsp16/nsp10 complex of SARS-CoV
(n=3, mean values 6 SD). (C)
32P-labeled G*pppG-RNA was used as
substrate to test the methylation activities of nsp16/nsp10, nsp16, and
nsp10 respectively. Vaccinia VP39 29-O-MTase was used as a positive
control (n=3, mean values 6 SD).
doi:10.1371/journal.ppat.1002294.g001
Figure 2. SAM binding analyses of SARS-CoV nsp14, nsp16 and
nsp10. (A) 12% SDS-PAGE analysis of SAM UV cross-linking with nsp16
(at pH 7.5 and 8.0) (lanes 1–2), nsp16/nsp10 with different ratios (lanes
3–4), and nsp10/nsp14/nsp16 (lane 5). Nsp10/nsp12N and nsp10/nsp3-
SUD (lanes 6–7) were used as controls. The positions of marker proteins
are indicated on the left. (B to D) ITC profiles for the binding of SAM to
nsp16 (B), nsp10 (C), and nsp16/nsp10 complex (D), respectively. The
top panels represent the raw data for sequential injections of SAM
(150 mM) into nsp16, nsp10 and nsp16/nsp10 complex. The bottom
panels show the plots of the heat evolved (kilocalories) per mole of
SAM.
doi:10.1371/journal.ppat.1002294.g002
SARS-CoV 29-O-Methylation Mechanisms by nsp16/10
PLoS Pathogens | www.plospathogens.org 3 October 2011 | Volume 7 | Issue 10 | e1002294alone is apyretic, resulting in random peaks around 0-baseline in
the plots of power versus time (Figures 2B and 2C). The bottom
panels in Figures 2B-D plot the heat evolved per mole of SAM
added, corrected for the heat of SAM dilution, against the molar
ratio of SAM to nsp16 (Figure 2B), nsp10 (Figure 2C), and nsp16/
nsp10 complex of SARS-CoV (Figure 2D). The thermodynamic
parameters for the binding between SAM and nsp16/nsp10
complex (N=0.87360.0817 sites, DbH0
m =218.12611.07 kcal
mol
21, Kd=5.5961.15 mM, and DbS0
m =236.7 cal mol
21 K
21)
were obtained by fitting the data to a single set of identical sites
model, indicating that SAM bound to nsp16/nsp10 complex with
a moderate affinity in the absence of DTT. The N value indicated
the binding stoichiometry and it suggested that the molecular ratio
of SAM to nsp16/nsp10 complex is 1:1. As the observed N value is
less than 1, it may indicate that not all nsp16 bound with nsp10 to
form nsp16/nsp10 complex in the assays. As shown by the value of
dissociation constant (Kd), the binding affinity between SAM and
nsp16/nsp10 complex was moderate. The mutual binding affinity
of SARS-CoV nsp10 and nsp16 was also measured by ITC, and
the Kd value was 2.1160.97 mM, which indicated similar binding
affinity to that of SAM and nsp16/nsp10 complex. Taken
together, these results showed that nsp10 is required for nsp16
to bind the methyl donor SAM and the binding affinity of SAM
and nsp16/nsp10 complex is moderate.
Nsp10 assists nsp16 in binding m7GpppA-capped RNA
We then tested whether nsp10 is required for specific binding of
m7GpppA-capped RNA. In gel shift assays in the absence of zinc
ions, neither nsp10 nor nsp16 could shift the RNA bands
(Figure 3A, lanes 1 and 2) but nsp14 and the complex of nsp16
and nsp10 could (Figure 3A, lanes 6 and 3). In the presence of zinc
ions, nsp10 as zinc finger protein could bind RNA non-specifically
(Figure 3A, lane 5). The complex of nsp16 and nsp10 did not
associate with m7GpppG-capped RNA (Figure 3B) and cap
analogues (m7GpppA and m7GpppG) (Figures 3C and 3D). These
results indicate that SARS-CoV nsp10 promotes nsp16 to
specifically bind m7GpppA-capped RNA. To confirm these
results, we adopted pull-down assays by using hexahistidine-
tagged proteins and radiolabeled RNAs or cap analogues. As
shown in Figure 3E, pull-down of nsp16 and nsp10 mixture by
nickel-nitrilotriacetic acid (Ni-NTA) resin gave rise to high level of
radioactive signal for *m7GpppA-capped RNA (where * indicates
that the methyl group was
3H labeled) while nsp10, nsp16, or nsp5
alone could not pull down the labeled RNA. Also in this testing
system, nsp16/nsp10 complex had a low binding affinity to
*m7GpppG-capped RNA and cap analogues (*m7GpppA and
*m7GpppG) (Figure 3E). The pulled-down proteins were further
checked by Western blotting to confirm the presence of the
indicated proteins (Figure 3F). These results collectively showed
that the nsp16 could bind specifically to m7GpppA-capped RNA
only in the presence of nsp10.
Furthermore, we also analyzed the binding specificity and
thermodynamics between nsp16/nsp10 and capped RNA in ITC
assays. The thermodynamic changes are shown for nsp16
(Figure 3G), nsp10 (Figure 3H) and nsp16/nsp10 complex of
SARS-CoV (Figure 3I) when added to the solution of m7GpppA-
capped RNA, respectively. The top panels in Figures 3G-I show
raw ITC curves and the bottom panels plot the heat evolved per
mole of the injected protein, corrected for the heat of the
corresponding proteins dilution, against the molar ratio to
m7GpppA-capped RNA. The titration curves show that
m7GpppA-capped RNA binding to nsp16/nsp10 complex is
exothermic, resulting in negative peaks in the plots of power versus
time (Figure 3I). However, all others were apyretic, resulting in
random peaks around 0-baseline in the plots of power versus time
(Figures 3G and 3H). The binding affinity of nsp16/nsp10
complex with m7GpppA-capped RNA is higher than that with
SAM as shown by the thermodynamic parameters for the binding
between nsp16/nsp10 complex and m7GpppA-capped RNA
(N=0.84060.0711 sites, DbH0
m =218.5862.171 kcal mol
21,
Kd=1.2160.41 mM, and DbS0
m =235.2 cal mol
21 K
21). We
Figure 3. RNA substrate binding analyses of nsp10 and nsp16
of SARS-CoV. (A) Gel shift assays were performed by 8% N-PAGE to
analyze the binding of
32P-labeled m7G*pppA-RNA incubated with
nsp10, nsp16, and nsp16/nsp10, respectively (lanes 1–3). There was no
protein in the mock as negative control (lane 4). Nsp10 (with 2 mM
ZnCl2) and nsp14 were used as positive controls (lanes 5–6). (B)
32P-
labeled m7G*pppG-RNA was incubated with nsp10, nsp16, nsp16/
nsp10, and mock respectively (lanes 1–4). Mixtures were analyzed by
8% N-PAGE. (C)
32P-labeled m7G*pppA cap analogue was incubated
with different proteins as in (A). Mixtures were analyzed by 14% N-
PAGE. (D)
32P-labeled m7G*pppG cap analogue was incubated with
different proteins as in (B). Mixtures were analyzed by 14% N-PAGE.
Positions of the free RNA substrates and shifting RNA substrates are
indicated on the left. Black arrows indicate shifting RNA bands in each
lane. (E) Different
3H-labeled RNA substrates were used to test the
binding affinities to nsp10, nsp16, and nsp16/nsp10. His6-nsp5 was a
negative control (n=2, mean values 6 SD). (F) 30 mL of the final
suspensions from (E) were analyzed by Western Blotting analysis. (G to I)
ITC profiles for the binding of nsp16 (G), nsp10 (H), and nsp16/nsp10
complex (I), respectively to m7GpppA-capped RNA. The top panels
represent the raw data for sequential injections of nsp16, nsp10 and
nsp16/nsp10 complex into m7GpppA-capped RNA (7 mM). The bottom
panels show the plots of the heat evolved (kilocalories) per mole of
purified proteins.
doi:10.1371/journal.ppat.1002294.g003
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(m7GpppA and m7GpppG) were added to nsp16/nsp10 complex
in ITC, but neither of the two cap analogues showed exothermic
binding (data not shown), which suggested that the cap analogues
are not the substrate of nsp16/nsp10 complex.
All together, these data showed that nsp10 plays an essential
role in the specific binding of m7GpppA-capped RNA by nsp16.
However, m7GpppG-capped RNA and cap analogues can not
bind to the nsp16/nsp10 complex, and thus can not be used as
substrate by 29-O-MTase of SARS-CoV.
Based on the results presented above, it is suggested that SARS-
CoV nsp10 may either stabilize the SAM-binding pocket of nsp16
or change the conformation of nsp16 so as to efficiently take in and
hold the SAM molecule. Furthermore, the association of nsp10
with nsp16 may provide a proper groove for binding and holding
of m7GpppA-capped RNA substrate. We thus expected to reveal
the details of SAM- and RNA-binding and stimulation mecha-
nisms from the crystal structure of nsp16/nsp10.
Structure determination and general features of the
nsp16/nsp10 complex
To obtain crystals of nsp16/nsp10 protein complex combined
with its MTase co-substrate SAM, 66histidine-tagged nsp16 and
66histidine-tagged nsp10 with nsp11 extension were expressed
individually in Escherichia coli cells and co-purified with Ni-NTA
resin. The protein mixture of purified nsp16 and nsp10 was
supplemented with methyl donor SAM to obtain protein complex
and then applied to crystallization by the hanging-drop vapor
diffusion method. Crystals appeared readily in hanging drops and
were diffracted to high resolution at 2.0 A ˚ under X-rays from
synchrotron radiation source. The structure was solved subse-
quently by multi-wavelength anomalous diffraction method taking
advantage of selenomethionine substituted crystals (see Materials
and Methods). Within one asymmetric unit in the crystals, one
nsp10, one nsp16 and one SAM molecule were identified
unambiguously. Residues in both nsp10 and nsp16 were clearly
traced except the C-terminus after Ser129 in nsp10 and the nsp11
extension. The atomic coordinates of the structure have been
deposited in the Protein Data Bank (PDB) as entry 3R24.
The structure of nsp16 (Figures 4A and 4B) exhibits the
characteristic fold of the class I MTase family, comprising a seven-
stranded b-sheet surrounded by a-helices and loops [32]. Search
of the PDB using DALI [33] identified high structural similarity of
nsp16 with FtsJ (PDB entry 1EIZ), a partner-independent MTase
from E. coli [34], with a 2.6 A ˚ root-mean square deviation (RMSD)
for 179 aligned Ca (from Y30 to A209 of nsp16 with 16%
sequence identity and Dali Z-score 26.6). The residues 30-209 of
nsp16 form the core MTase domain. Nevertheless, some
differences between the two structures are evident. The most
significant difference lies in the aD helix, which is visible on the
surface of FtsJ (Figure S1E) but invisible for nsp16 (Figure S1B).
The aD helix is important for both SAM-binding and RNA cap-
binding, and it is very short in partner-dependent nsp16 29-O-
MTase but relatively long in all other known viral 29-O-MTases,
including vaccinia virus VP39 (PDB entry 1AV6) (Figure S1C),
Dengue virus NS5 MTase (PDB entry 1L9K) (Figure S1D), and
Bluetongue virus VP4 29-O-MTase (PDB entry 2JHP) (Figure
S1F), which are partner-independent MTases. The differences
between nsp16 and other 29-O-MTases are shown in the
structure-based alignment of 29-O-MTases (vaccinia virus VP39,
Flavivirus NS5 MTase, and FtsJ) (Figure S2).
The structure of the stimulatory protein nsp10 in nsp16/nsp10
complex (Figures 4A and 4B) is consistent with the structure of
nsp10 reported previously [35,36],indicating that the structure of
nsp10 is not impacted by the interaction between nsp16 and
nsp10. Nsp10 can be roughly segregated into three regions: a
helical domain at the N terminus followed by an irregular b-sheet
region, and a C-terminal loop region. Two zinc ions were clearly
identified in nsp10, which formed the center of two zinc fingers,
one coordinated by Cys-74, Cys-77, His-83 and Cys-90, and the
other coordinated by Cys-117, Cys-120, Cys-128 and Cys-130.
The two zinc fingers render nsp10 the ability to bind polynucle-
otide chains in a nonselective manner in the presence of zinc ions
[35,36,37].
During the review process of this work, a structure of nsp16/
nsp10 complex of SARS-CoV was reported by Decroly and
colleagues [38], which is generally the same as the structure
described in this work. The major difference lies in that the
structure we solved contains the methyl donor SAM that was
purposely supplemented in the protein mixture, and the one by
Decroly and colleagues contains S-adenosylhomocysteine (SAH)
which is the product of SAM after methyltransfer and may be
captured from the medium by nsp16 that was co-expressed with
nsp10 in bacterial cells [38]. The atomic coordinates of nsp16/
nsp10 structure solved by Decroly et al. have not been released
until now, and thus detailed comparison of the two structures is
not available.
The nsp10/nsp16 interface
Nsp10 and nsp16 formed a protein complex through an
interaction surface covering approximately 1767 A ˚ 2 in total,
indicating a very stable interaction. The interaction surface on
nsp10 was dominated by hydrophobic interactions in center with
surrounding hydrophilic interactions. By using the online software
Interfaces and Assemblies of EMBL-EBI (http://www.ebi.ac.uk/
msd-srv/prot_int/pistart.html), it was found that significant
contacts between nsp10 and nsp16 involve residues 40–47/69–
84/93–96 of nsp10, and residues 37–48/76–91/102–110/244–
248 of nsp16 (Figures 4). Close inspection revealed a cluster of
important residues involved in nsp16-nsp10 interaction, including
Val-42, Met-44, Gly-70, Ser-72, Arg-78, His-80, Lys-93, Gly-94,
Lys-95 and Tyr-96 in nsp10, in agreement with hotspots identified
in biochemical assays [39]. Intermolecular hydrogen bonds exist
between Gly-70/Ala-71/Gly-94 of nsp10 and Asp-106 of nsp16,
Lys-93 of nsp10 and Ser-105 of nsp16, Leu-45 of nsp10 and Gln-
87 of nsp16, Tyr-96 of nsp10 and Ala-83/Gln-87 of nsp16. There
are two salt bridges between His-80 (nitrogen atoms ND1 and
NE2) of nsp10 and Asp-102 (oxygen atom OD2) of nsp16
(Figures 4 D and 4E). Hydrophobic interactions were involved
between Leu-45 in nsp10 and a hydrophobic pocket composed of
Ile-40/Thr-48/Leu-244/Met-247 in nsp16, and Tyr-96 in nsp10
and a hydrophobic pocket consisting of Val-84, main chain of Gln-
87 and Arg-86 from nsp16 (Figures 4C and 4E).
Biochemical assays showed that only nsp16/nsp10 complex
could bind the substrates m7GpppA-RNA and SAM, and execute
the 29-O MTase activity. Therefore, mutations on the interaction
surface of nsp16/nsp10 complex which can block this interaction
should influence the substrates binding, and consequently the
MTase activity of nsp16. A double mutant (H83A/P84A) and a
triple mutant (Y76A/C77A/R78A) at the interaction surface of
nsp10 were generated. These mutants almost completely abolished
the SAM (Figure 5C) and m7GpppA-RNA (Figure 5D) binding of
nsp16, and also abrogated MTase activity (Figures 5A and 5B).
The main chain N atom of Gly-70 in nsp10 formed a hydrogen
bond with Asp-106 of nsp16. The single mutation G70A only
slightly influences this main chain interaction, and accordingly, it
slightly impaired the SAM- and RNA-binding activity of nsp16
(Figures 5C, lane 3 and 5D) and attenuated by 30% the 29-O-
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results were obtained by Lugari et al., except for an Y96F
mutation, which increased both the nsp10-nsp16 affinity and the
MTase activity of nsp16 [39]. In the interaction surface of nsp16/
nsp10, the side chain of Tyr-96 in nsp10 stacks to the hydrophobic
pocket consisting of Val-84, main chain of Gln-87 and Arg-86 in
nsp16. Compared with tryptophan, the side chain of phenylala-
nine exhibits a stronger hydrophobicity. Therefore, Y96F
mutation may strengthen this hydrophobic interaction of nsp10
and nsp16, and thus enhance nsp16/nsp10 MTase activity. This
observation suggests that the hydrophobic interaction by the
aromatic nucleus of Tyr-96 is more important than the hydrogen
bond made by its hydroxyl group for maintaining the interaction
surface with nsp16. Taken together, biochemical analysis of the
critical residues involved in the interaction interface was consistent
with the structural observations.
A unique mode of SAM binding to nsp16/nsp10 complex
Methyl donor SAM was added to protein mixture used for
crystal screening, and SAM molecule is visible in the crystal
Figure 4. Structural insight into the nsp16/nsp10 complex of SARS-CoV. (A) Two orthogonal views of the overall structure of nsp16/nsp10
complex. The proteins are shown in ribbon with green (nsp10) and cyan (nsp16). SAM is depicted in a stick model and colored by atoms (C: salmon,
O: red, N: blue, H: white). (B) Schematic diagram of topology of the nsp16/nsp10 complex colored by proteins as in (A). Hydrogen bonds located in
the interaction sites are shown by dotted lines. (C) Interaction surface of nsp16/nsp10 complex. The main chain of nsp10 is show in ribbon with
green. Residues (Leu-45, Gly-70, Ala-71, His-80, Lys-93, Gly-94, Tyr-96) which interact with nsp16 are depicted in a stick model and colored by atoms
(C: cyan, O: red, N: blue, H: white). Nsp16 is shown in ribbon with electrostatic potential surface of 20% transparency. The surface charge is depicted
as blue in positively charged areas, red in negatively charged areas, and white in electroneutral areas. (D) Interaction surface of nsp16/nsp10 complex.
The main chain of nsp10 is show as ribbon and colored in green. Residues (Leu-45, Gly-70, Ala-71, His-80, Lys-93, Gly-94, Tyr-96) which interact with
nsp16 are shown as sticks and colored by atoms (C: cyan, O: red, N: blue, H: white). The main chain of nsp16 is show as ribbon and colored in light
magenta. Residues (Gln-87, Asp-102, Ser-105, Asp106) which interact with nsp10 are shown as sticks and colored by atoms (C: orange, O: red, N: blue,
H: white). Hydrogen bonds and salt bridges are shown as yellow dotted lines. (E). Residues involved in the direct interaction of nsp16 and nsp10 are
listed in the lower and upper parts, respectively.
doi:10.1371/journal.ppat.1002294.g004
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C-terminus of strands b1a n db2, similar to most SAM-
dependent MTases [32] (Figures 4A and 4B). As shown in
Figure 6A, the adenosine moiety of SAM is stacked among Phe-
149, Met-131 and Cys-115 in nsp16 through Van der Waals
force, and polar contacts also exist, such as those of adenine N6
with side chain of Asp-114, N1 with main chain of Cys-115,
and N3 with main chain of Leu-100. The 29-a n d3 9-OH of the
adenosine ribose of SAM are stabilized by the side chain of
Asp-99 and the side chain of Asn-101 via hydrogen bonds. The
hydrophobic patch of the ribose packs against Met-131 and the
hydrophobic main chain of Tyr-132. The amino group of the
methionine moiety of SAM is maintained by three polar
contacts: N atom forms a hydrogen bond with main chain
carbonyl group of Gly-71, side chain of Tyr-47 and Asp-130;
hydroxyl O atom interacts with main chain of Gly-81 and main
chain of Ala-72 and Gly-73; and carbonyl O atom interacts
with side chain Asn-43 (Figure 6A).
The crystal structure of nsp16/nsp10 complex shows that the
SAM binding cleft of nsp16 is composed of three loops: loop
71–79 (residues 71–79) together with loop 100–108 (residues
100–108) forming a wall on one side of the cleft and loop 130–
148 (residues 130–148), which is followed by aDh e l i x ,f o r m i n g
a wall on the other side. Several ‘hot spot’ residues were located
at the loop regions (Leu-100, Asn-101, Asp-130, Met-131, Tyr-
132) (Figure S1A). Structural analysis revealed that the loop
followed by aD helix of partner-independent 29-O-MTases is
shorter than that of nsp16 (loop 130–148) and is sustained by
rigid aD helix such as to form a stable wall to keep the SAM
inside the cleft. In contrast, in the SAM-binding pocket of
nsp16, the corresponding loop (loop 130–148) is long and
flexible while the supporting rigid aD helix is short (Figure S2).
Moreover, the loop 100–108 of nsp16 is also longer and more
flexible than that in other 29-O-MTases. These structural
features may make the SAM-binding cleft more flexible and
thus in need of extra support from the stimulatory factor nsp10.
In Flavivirus NS5 MTase, the loop corresponding to residues
100–108 was much longer for unknown reasons, but due to the
strong sustaining effect of the long aD helix, the SAM-binding
c l e f to fN S 5M T a s ei sp o s t u l a t e dt ob em o r es t a b l et h a nt h a to f
nsp16. Therefore, it appears that at least one stable wall is
essential for the SAM binding cleft to maintain the SAM
binding activity. In the crystal structure of nsp16/nsp10
complex, one hydrogen bond forms between Lys-93 of nsp10
and Ser-105 of nsp16, and two salt bridges exist between His-80
ND1 and NE2 from nsp10 with Asp-102 OD2 from nsp16
(Figure 6B). Both Ser-105 and Asp-102 of nsp16 are located in
the flexible loop region 100–108, which stabilizes one wall of
the SAM binding cleft (Figures 6C and S1A), and consequently
promotes the SAM binding activity of nsp16/nsp10 complex
(Figure 2). This phenomenon of enhancing the SAM-binding
activity by stabilization of the binding cleft via protein-protein
interaction is observed for the first time, revealing a unique
mode of SAM binding among the 29-O-MTases.
Figure 5. Biochemical analyses of nsp10 mutants. (A) TLC analysis of nuclease P1-resistant cap structures released from
32P-labeled m7G*pppA-
RNA methylated by nsp16/nsp10 G70A, nsp16/nsp10 K93A, nsp16/nsp10 Y76A/C77A/R78A, and nsp16/nsp10 H83A/P84A (lanes 5–8), respectively.
Nsp16, nsp16/nsp10, and nsp10 were used as controls (lanes 3, 4, and 9). The positions of origin and migration of m7G*pppA, G*pppA, and
m7G*pppAm (lanes 1, 2, and 10) are indicated on the left. The bands located between origin and G*pppA are free a-
32P-GTP. (B) m7GpppA-RNA was
used to test the methylation activities of nsp10 mutants complexed with nsp16 of SARS-CoV (n=2, mean values 6 SD). (C) 12% SDS-PAGE analysis of
SAM UV cross-linking with nsp16/nsp10 G70A, nsp16/nsp10 K93A, nsp16/nsp10 Y76A/C77A/R78A, and nsp16/nsp10 H83A/P84A (lanes 3–6),
respectively. Nsp16, nsp16/nsp10, and nsp10 were used as controls (lanes 1, 2, and 7). (D)
3H-labeled *m7GpppA-RNA substrates were used to test
the binding affinities to nsp16/nsp10 G70A, nsp16/nsp10 K93A, nsp16/nsp10 Y76A/C77A/R78A, and nsp16/nsp10 H83A/P84A. Nsp16, nsp10, and
nsp5 were negative controls (n=2, mean values 6 SD).
doi:10.1371/journal.ppat.1002294.g005
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nsp16/nsp10 complex
Previous studies have demonstrated the existence of a conserved
motif for methyl-transfer: K-D-K-E residues among various 29-O
MTases which catalyze an SN2-reaction-mediated 29-O methyl
transfer [40,41,42]. Structure-based alignment of nsp16 with
VP39, NS5 MTase and FtsJ highlights these four strictly conserved
residues (Lys-46, Asp-130, Lys-170 and Glu-203) in nsp16 (Figure
S2). In the crystal structure, the SAM methyl group stretches out
to the surface provided by the K-D-K-E motif (Figures 7B and S3),
which are located at the bottom of the central groove, and might
bind the first adenine nucleotide, conserved in SARS genomic and
subgenomic RNAs, as the acceptor of methyl group during the
methylation. This was also demonstrated by the crystal structures
of other 29-O MTases [40,43,44,45]. The central groove of nsp16
is positively charged (Figures 7C and 7D), and the phosphate
backbone of the cap-containing RNA is highly negatively charged.
These observations indicate that the central groove in nsp16 is
most likely the cap binding site. However, the cap binding groove
of nsp16 is built by two flexible loops (residues 26-38 and residues
130–148) in nsp16 (Figures 7A and 7B), which replace the highly
stable a-helices (A1, A2 and half of the aD) in flavivirus NS5
MTase along the cap-binding groove [46] (Figure S1D).
Therefore, it is obvious that the RNA binding groove of nsp16
is too flexible and unstable to hold the substrate cap-0 RNA
(Figures 7A and 7B), which explains why nsp16 alone shows an
extraordinary low affinity for both m7GpppA-RNA and
m7GpppA cap analogue in biochemical assays (Figures 3A, lane
2, 3C and 3E).
To further characterize the substrate RNA binding site of nsp16/
nsp10 complex, we performed molecular modeling of nsp16/nsp10
complexwithm7GpppAAAAAA (m7GpppA-RNA)and m7GpppG-
AAAAA (m7GpppG-RNA), respectively (Figure 7C, 7D and 7E).
m7GpppG-RNA was derived from the structure of vaccinia virus 29-
O-MTase VP39 (PDB entry: 1AV6), and m7GpppA-RNA was
mutated manually from m7GpppG-RNA. As shown in Figures 7C
and 7D, the first three transcriptional nucleotides are contacted with
nsp16 and the following transcriptional nucleotides are contacted
with nsp10. This docking model shows that nsp10 is involved in
substrate RNA binding in nsp16/nsp10 complex, as the existence of
nsp10 extends the positively charged area (Figures 7C and 7D),
consequently elongating the RNA-binding groove of nsp16, which
may increase the RNA-binding affinity.
In biochemical assays, nsp16/nsp10 complex indeed showed
increased binding affinity for m7GpppA-capped RNA (Figures 3A
and 3E) but still maintained a very low affinity for m7GpppA cap
analogue (Figures 3C and 3E). These results indicate that
m7GpppA alone is not long enough to reach the extended
positively charged area provided by nsp10 and additional
nucleotides following the m7GpppA cap are needed for binding
to the nsp16/nsp10 complex. As shown previously, m7GpppAC5
acted as an effective substrate of nsp16/nsp10 complex [25],
suggesting that as few as 5 extra nucleotides are sufficient. Nsp10
itself possesses two zinc-finger motifs and has the ability to bind
polynucleotides nonspecifically in the presence of zinc ions
(Figure 3A, lane 5) [37]; therefore the RNA binding by the
nsp10 portion is not sequence-specific. In conclusion, the RNA-
binding groove extension provided by nsp10 may contribute to
hold the extended RNA chain following the m7GpppA cap and
stabilize the interaction between m7GpppA-RNA and nsp16 cap
binding site.
By analysis of RNA binding site of nsp16/nsp10 complex, an
unexpected promontory composed of residues 74–77 at the
catalysis activity surface of nsp16 could be readily identified,
which might have steric hindrance for binding GpppG-capped
RNA. The residue Asp-75 (D75) stretches out to the C2 atom of
first transcribed nucleotide (Figure 7E) and may thus functions as
the specificity determinant. We also performed structural align-
ment analysis between nsp16/nsp10 complex and VP39 (PDB
entry: 1AV6) at the methyltransferase activity site (Figure 7F and
7G). Compared with VP39, the binding pocket for substrate RNA
of nsp16/nsp10 complex appears more limited, due to the
existence of residues 74–77, especially D75. The amino group
Figure 6. Structural mechanisms of nsp10 in stimulating the
SAM binding of nsp16. (A) Residues of nsp16 interacting with SAM.
All residues and SAM are shown as sticks, water as blue dots, and
hydrogen bonds as green dotted lines. Nsp10-mediated stabilization of
the SAM binding cleft of nsp16 in ribbon model (B) and surface model
(C). Nsp16 is colored in cyan. Residues 71–79 and residues 100–108 are
colored in magenta. Nsp10 is shown as ribbon and colored in green.
SAM is colored in yellow. His-80 and Lys-93 are shown as sticks and
colored by atoms (C: green, O: red, N: blue). Hydrogen bonds are shown
as yellow dotted lines. In (B), Asp-102, Ser-105 of nsp16 are shown as
sticks and colored by atoms (C: green, O: red, N: blue).
doi:10.1371/journal.ppat.1002294.g006
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m7GpppG-RNA seems too close to the side chain of D75
compared with m7GpppA-RNA, which has no amino group at C2
atom. This structural difference might explain why m7GpppG-
RNA exhibits a relatively low affinity to the nsp16/nsp10 complex
(Figure 3E).
Discussion
SARS-CoV nsp16 is the only 29-O-MTase currently known that
needs a stimulatory subunit for exerting its methyltransferase
activity. In this work, we showed that nsp10 could stimulate nsp16
to bind the methyl donor SAM and the capped RNA substrate.
These mechanisms could be explained based on the crystal
structure of nsp16/nsp10 complex, and confirmed by mutational
analysis. This is reminiscent of the activation mechanism of the
N7-MTase involved in vaccinia virus mRNA capping [47]. The
vaccinia N7-MTase consists of two subunits, the catalytic subunit
located in the C-terminal domain of D1 protein and the
stimulatory subunit D12. The activation of D1 MTase activity
by D12 is achieved through increase of the substrate and co-
substrate affinity as well as enhancement of the stability of D1
protein [47]. Structural analysis revealed that D12 is structurally
homologous to cap 29-O-MTase with a truncation of the SAM-
binding domain [48]. In contrast, SARS-CoV nsp10 does not
possess an MTase fold and is structurally not similar to any other
proteins deposited in the PDB database [35,36]. Vaccinia virus
VP39 protein acts as the viral 29-O-MTase but it does not require
a stimulatory factor for its enzymatic activity [40,49].
Based on the crystal structure of nsp16/nsp10 complex and
biochemical analysis, the mechanisms of nsp16 binding to
substrates m7GpppA-RNA and SAM with the assistance of
nsp10 were revealed. Our data showed that nsp10 acts as a
buttress supporting the seemingly flexible loop 100–108 critically
involved in SAM-binding (Figures 6B and 6C) and thus enhancing
the SAM-binding affinity. For binding of nsp16 to capped RNA, it
appears in the structure that the RNA binding groove in nsp16 has
only sufficient space for binding the 59-cap of the RNA, but for
stable interaction of nsp16 and capped RNA substrate, nsp10 is
needed to extend the groove and accommodate extra nucleotides
following the cap (Figures 3 and 7). The residues Lys-93 and His-
80 in nsp10 are involved in the interaction with the loop 100–108
of nsp16, and our results showed that the K93A mutation reduced
the SAM-binding activity significantly but not the RNA-binding
affinity (Figures 5C and 5D), indicating that this site is essential for
SAM-binding but not for the overall interactions of nsp16 and
nsp10 [39]. Similar results were obtained for H80R mutation (data
not shown). The K93A mutation caused an overall decrease by
60% in the 29-O MTase activity of nsp16/nsp10 complex
(Figures 5A and 5B). The mutational and biochemical analysis
of this and previous studies [39] further proved the structural
model for the SAM and RNA binding mechanisms. It was
reported that alanine replacements of nsp10 in murine hepatitis
virus (MHV) resulting in lethal phenotypes mapped to a central
core of nsp10 that is resistant to mutation, and the rescued viruses
with mutations in nsp10 reduced viral RNA synthesis [50]. As
most of these mutations of nsp10 were located at the interaction
interface of nsp16/nsp10 complex, they might influence the
activities of viral 29-O-MTase.
Figure 7. Structural mechanisms of nsp10 in stimulating the
binding of capped RNA to nsp16. The cap-binding groove of nsp16
is shown as surface with 20% transparency (A) and ribbon (B). The
structural model of nsp16/nsp10 complex is colored by the Debye-
Waller factor, based on which the warm colored regions are highly
flexible and mobile. The K-D-K-E motif residues of nsp16 (Lys-46, Asp-
130, Lys-170 and Glu-203) are shown as sticks and colored in magenta.
Nsp10 is shown as ribbon and colored in green. Molecular docking of
m7GpppA-RNA or m7GpppG-RNA on RNA-binding groove of nsp16/
nsp10 complex. Overall structure of docking model of nsp16/nsp10
complex and m7GpppA-RNA (C, D) and details of methyltransferase
activity site of nsp16 (E). Nsp16 is shown as ribbon and electrostatic
potential surface with 20% transparency. Nsp10 is shown as ribbon (C)
or electrostatic potential surface with 20% transparency (D). SAM is
shown as sticks and colored in yellow. The methyl group of SAM is
colored in blue. Zinc ions are shown as spheres. The m7GpppA-RNA is
shown as sticks and the first two nucleotides are colored by atoms (C:
green, O: red, N: blue, P: orange) and the next nucleotides are colored in
magenta. Structural alignment of methyltransferase activity site from
VP39 (PDB entry: 1AV6) and SARS-CoV nsp16 docking with m7GpppA-
RNA (F) or m7GpppG-RNA (G), respectively. VP39 is superimposed with
SARS-CoV nsp16 (F, G). VP39 is shown as surface and colored in orange,
and nsp16 is shown as ribbon and colored in green, with Asp-75 (D75)
shown as sticks and colored in cyan.
doi:10.1371/journal.ppat.1002294.g007
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same as the nsp10 monomer [35]. Compared the crystal structure
of nsp16/nsp10 complex with dodecamer of nsp10 [36], we found
that the interaction surface of nsp16-nsp10 has partial overlap with
the contact surface of nsp10 within dodecamer. Also the surface of
nsp10 which may associate with nsp16 faces to the inner space of
spherical nsp10 dodecamer, which does not leave sufficient space
for nsp16 binding. This indicates that nsp10 dodecamer structure
may not be involved in the stimulation of nsp16 29-O-MTase
activity. However, the existence of nsp10 dodecamer structure
during viral infection could not be excluded because nsp10 is
translated up to several times more than nsp16 [51,52] and the
surplus nsp10 may form structures other than the nsp16/nsp10
complex. In addition, nsp10 is found in the nsp4-nsp10 precursor
[53] and abolishment of the nsp9-nsp10 cleavage site resulted in
viable virus [54]. This observation suggests that fusion of nsp10
with nsp9 should not disrupt the essential activities of nsp10
involved in virus replication. In the nsp16/nsp10 complex, the N-
terminal part of nsp10, which connects with nsp9 in the nsp9-
nsp10 fusion, is exposed at the surface of the complex. The first 9
amino acids at the very N-terminus of nsp10 are invisible in the
crystal structure, indicating that they might form a flexible loop. In
addition, the C-terminus of nsp9 is located at the surface of this
non-specific single-stranded RNA binding protein [51,55]. Taken
together, this suggests that the nsp9-nsp10 is structurally capable of
forming a complex with nsp16 and may thus stimulate the 29-O-
MTase activity of nsp16. The nsp9-nsp10 fusion has less
propensity to form a dodecamer, which may further weaken the
biological relevance of the nsp10 dodecamer structure observed
previously [36].
Nsp10 represents a multi-functional protein involved in viral
RNA synthesis, polyprotein processing and RTC assembly
[50,53,54]. It was shown that nsp10 could interact with both
29-O-MTase nsp16 and N7-MTase nsp14 [30,31], suggesting
that a single nsp10 molecule or its dimer could associate with
both nsp16 and nsp14 at the same time in the RTC. Thus, one
model can be proposed to explain the RNA cap methylation
during coronavirus replication: After translation and processing
of polyproteins 1a and 1ab, the mature nsp14, nsp16 and nsp10
form the RNA methylation apparatus, where SAM is bound by
nsp14 and nsp16 in the presence of nsp10. The newly
transcribed viral RNA is capped by the unknown capping
enzyme (GTase) and bound to nsp10. The 59-end of the RNA is
first associated with nsp14 and methylated at the N7 position of
the cap guanine. Next, the conformation of the RNA-protein
complex is altered, and the 59-end of viral RNA is transferred
from the RNA-binding groove of nsp14 to that of nsp16,
resulting in second methylation at the 29-O-site in the ribose of
the first nucleotide following the cap. Further experiments are
needed to confirm this model.
Cellular and DNA virus capping enzymes generally are not
sequence-specific as they accommodate a large number of
different mRNA species. However, the genomes of RNA viruses
are very small in comparison with DNA genomes and usually
encode just a few genomic and subgenomic mRNAs with
conserved 59-ends. It has been shown that the flavivirus MTases
are sequence-dependent [42,56]. In our previous work, we
showed that the SARS-CoV nsp14 N7-MTase is sequence-
unspecific as it could methylate the RNA cap of different RNAs
both in vitro and in yeast cells [8]. However, in the current study,
we showed that the nsp16 29-O-MTase is sequence-dependent as
it could only methylate m7GpppA-capped RNA, where the first
nucleotide is absolutely restricted to adenosine. Structural
modeling analysis suggests that the amino residues at positions
74–77 of nsp16 may be the determinant for such sequence
specificity (Figures 7C, 7D and 7E). In addition, the unknown
coronavirus GTase may also contribute to the specificity of
coronavirus capping enzymes. In coronavirus life cycle, genomic
RNA replication and subgenomic RNA transcription take place
in association with double-membrane vesicle [3], and this
physical restriction may make the capping apparatus accessible
only to viral RNAs.
It is well known that mRNA capping and methylation play
important roles in mRNA stability, processing, transport and
protein translation. Very recently, it was found that 29-O-
methylation of the viral RNA cap is essential for RNA viruses to
avoid innate immune recognition by the host immune system
[23,24]. Thus, inhibition of viral MTase activity should be able to
suppress viral replication and attenuate viral virulence in infection
and pathogenesis. The MTase active site has been suggested as a
drug target for developing antiviral drugs [57,58,59]. However,
the MTase fold is structurally conserved between viral and cellular
MTases, and it is thus difficult to obtain antiviral compounds with
high specificity targeting MTase active sites. For this reason, it
looks more promising to target the interface of nsp16 and nsp10,
which is unique to coronaviruses.
In summary, we have characterized the SARS-CoV 29-O-
MTase and the activation mechanism of nsp16 by nsp10
biochemically and structurally. We found that nsp10 promoted
the substrate and co-substrate binding of nsp16 by increasing the
stability of the SAM-binding pocket and by extending the RNA-
binding groove of nsp16. The current findings not only provide
insights into the mechanism of SARS-CoV 29-O-methylation but
also facilitate design and development of highly specific antiviral
drugs targeting the nsp16/nsp10 interface.
Materials and Methods
Protein expression and purification
The coding sequences of SARS-CoV nsp10-nsp11 fusion
protein and nsp16 were PCR amplified from the cDNA sequence
of SARS-CoV strain WHU (gi: 40795428) [2,31] using the
primers as listed in Table S1. The nsp10-nsp11 fusion protein and
nsp16 genes (encoding residues Asn4240-Val4382 [35] and
Ala6776-Asn7073 of replicase pp1ab) were cloned into pET30a
(Novagen) (pET30a-His6-nsp10-nsp11, pET30a-His6-thrombin-
nsp16) to produce recombinant proteins carrying an N-terminal
His6-tag. The mutants of nsp10 (G70A, K93A, Y76A/C77A/
R78A, and H83A/P84A) were generated by overlap PCR with
mutagenic primers (Table S1) and cloned into pET30a as
described for wild-type nsp10-nsp11 fusion protein. All constructs
were verified by DNA sequencing. Both pET30a-His6-nsp10-
nsp11 and pET30a-His6-thrombin-nsp16 transformed E. coli BL21
(DE3) cells were grown at 37uC in Luria-Bertani (LB) medium
with 50 mg/mL kanamycin and induced with 0.4 mM isopropyl b-
D- thiogalactopyranoside (IPTG) at 16uC for 12–16 hours. The
SARS-CoV unique domain (SUD) of nsp3 (nsp3-SUD), nsp5, N-
terminal domain of nsp12 (nsp12N), and nsp14 protein expression
and purification were described previously [8]. The sequences of
the cDNA and proteins have been deposited in GenBank database
with accession numbers listed at the end of ‘‘Materials and
Methods’’ section.
To obtain nsp10-nsp11 and nsp16 protein complex, 1 L of
pET30a-His6-nsp10-nsp11 cells and 2 L of pET30a-His6-throm-
bin-nsp16 cells were mixed together and resuspended in buffer A
[50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM MgSO4,5 %
glycerol] supplemented with 10 mM imidazole. After sonication
and centrifugation, cleared lysates were applied to nickel-
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supplemented with a stepwise imidazole gradient of 20 mM,
50 mM, and 80 mM. Proteins were eluted with buffer A
supplemented with 250 mM imidazole, and 0.5 mM SAM. After
shaking at 4uC for 10 hours and centrifugation, the protein sample
was further purified on a Superdex 200 column (GE) equilibrated
with buffer A. Fractions containing the nsp16/nsp10 complex
(nsp11 region was degraded during the process, data not shown)
were concentrated to 10 mg/ml by ultrafiltration and frozen at
280uC for further use. The expression and purification conditions
of selenomethionine (SeMet)-labeled nsp16 and nsp10 (unlabeled)
protein complex were the same as for native nsp16/nsp10
complex except that modified M9 medium was used instead of
LB medium during the expression of nsp16.
Crystallization and data collection
Crystals were grown by the hanging-drop vapor diffusion
method. The drops contained 1 ml each of nsp16/nsp10 protein
complex [10 mg/ml in 50 mM Tris-HCl (pH 7.5), 150 mM
NaCl, 5 mM MgSO4, 5% glycerol, 5 mM SAM] and 1 mL
mother liquor. Protein crystals were obtained at 25uC after 24 h in
0.1 M MES, pH 5.0, 2 M NaCl, 0.1 M NaH2PO4, 0.1 M
KH2PO4. The crystals of SeMet labeled nsp16/nsp10 complex
were obtained in the same conditions. For data collection, the
crystals were cryocooled (by nitrogen gas stream, 100 K) in the
original mother liquor containing 20% (vol/vol) glycerol and
diffraction data sets were collected on beamline BL-17U1 at
Shanghai Synchrotron Radiation Facility (SSRF) for native
protein complex crystal and beamline 1W2B at Beijing Synchro-
tron Radiation Facility (BSRF) for SeMet labeled nsp16/nsp10
complex crystal. The diffraction data were processed and scaled
with the HKL2000 package. Data collection statistics are listed in
Table S2.
Structure determination and refinement
The structure was solved by the multi-wavelength anomalous
diffraction (MAD) method based on two sets of derivative data and
one set of native data. A preliminary model was readily built up by
Phenix package [60] from derivative data, which covered around
60% of whole structure. Most of the secondary structures were
obvious in the initial model, especially the 7-b-strand core. The
model was then used for refining and manual building against high
resolution native diffraction data. To speed up the refining
process, the sole nsp10 structure was introduced into the complex
by molecular replacement using Phaser [61] in CCP4 package
[62]. The CNS suite [63] and Phenix refinement program
(phenix.refine) [64] were used iteratively in refinement. Simulated
annealing, position refining and B-factor refining were used in
multiple rounds. The density for loop regions became visible
gradually as refinement proceeded. A SAM molecule and
coordinated zinc ion in nsp10 were included based on 2Fo-Fc
electron density. Structure validation was performed periodically
during refinement by Procheck [65,66]. Eventually most of the
protein sequences, except the disordered C-terminal tail in nsp10
and artificial tags generated from vectors, were involved in the
final structure, and ordered water molecules were added.
Molecular modeling
The methyltransferase domain in the structure of VP39 was
superimposed to nsp16 in the nsp16/nsp10 complex by LSQKAB
[67] in CCP4 package [62], and the RNA molecule in VP39 was
used to model the interaction between RNA and SARS nsp16/
nsp10 complex. The interface between RNA and nsp16/nsp10
was optimized by energy minimization using PHENIX [64] for 3
cycles.
Preparation of RNA substrates
The ATP-initiated RNA substrates representing the 59-terminal
259 nucleotides of the SARS-CoV genome and nonviral RNA
substrate comprising 52 nucleotides (with G as the first nucleotide)
were in vitro transcribed,
32P-labeled at cap structures
(m7G*pppA-RNA, G*pppA-RNA, or m7G*pppG-RNA, where
the * indicates that the following phosphate was radio-labeled.),
and purified as previously described [8]. RNAs containing
32P-
labeled cap-1 structure (m7G*pppAm-RNA) as positive control
were converted from cap-0 structure m7G*pppA-RNA by a
vaccinia virus 29-O-methyltransferase VP39 following the manu-
facturer’s protocol (Epicentre). RNAs containing unlabeled cap
structures (m7GpppA-RNA or m7GpppG-RNA) were prepared
by a vaccinia virus capping enzyme following the manufacturer’s
protocol (Epicentre) as well as
3H-labeled cap structures
(*m7GpppA-RNA or *m7GpppG-RNA), except that 10 mCi of
S-adenosyl [methyl-
3H] methionine (67.3 Ci/mmol, 0.5 mCi/ul)
was used as the methyl donor instead of cold SAM. The
32P-
labeled cap analogue (m7G*pppA or m7G*pppG) and
3H-labeled
cap analogue (*m7GpppA or *m7GpppG) were digested from
m7G*pppA-RNA/m7G*pppG-RNA and *m7GpppA-RNA/
*m7GpppG-RNA by nuclease P1 (Sigma) in 10 mM Tris-HCl,
pH 7.5, 1 mM ZnCl2 at 50uC for 30 min. All the RNA substrates
were extracted with phenol-chloroform and precipitated with
ethanol. The unlabeled cap analogues (m7GpppA, GpppA, and
m7GpppG) were purchased from New England BioLabs.
Biochemical assays for MTase activity
Purified recombinant or mutant proteins (0.5 mg) and 2610
3
cpm of
32P-labeled m7G*pppA-RNA or G*pppA-RNA substrates
were added to 8.5 mL reaction mixture [40 mM Tris-HCl (pH 7.5
or 8.0), 2 mM MgCl2, 2 mM DTT, 10 units RNase inhibitor,
0.2 mM SAM] and incubated at 37uC for 1.5 h. RNA cap
structures were liberated with 5 mg of nuclease P1 (Sigma), then
spotted onto polyethyleneimine cellulose-F plates (Merck) for
TLC, and developed in 0.4 M ammonium sulfate. The extent of
32P-labeled cap was determined by scanning the chromatogram
with a PhosphorImager [8].
MTase activity assays were carried out in 30 mL reaction
mixture [40 mM Tris-HCl (pH 7.5), 2 mM MgCl2, 2 mM DTT,
40 units RNase inhibitor, 0.01 mM SAM], with 1 mCi of S-
adenosyl [methyl-
3H] methionine (67.3 Ci/mmol, 0.5 mCi/ml),
1 mg of purified proteins or mutant proteins, and 3 mgo f
m7GpppA/m7GpppG-RNA substrates or other RNA substrates
(2 mM m7GpppA/GpppA/m7GpppG cap analogue or 15 mM
NTPs) at 37uC for 1.5 h.
3H-labeled product was isolated in small
DEAE-Sephadex columns and quantitated by liquid scintillation
[68].
SAM binding assay
25 mL reaction mixtures [40 mM Tris-HCl (pH 7.5), 2 mM
MgCl2, 2 mM DTT] containing 1 mg of purified proteins and
1 mCi of S-adenosyl [methyl-
3H] methionine (67.3 Ci/mmol,
0.5 mCi/ml) were pipetted into wells of a microtiter plate. The
reaction mixtures were incubated on ice and irradiated with 254-
nm UV light in a Hoefer UVC500 cross-linking oven for 30 min.
The distance of samples from the UV tubes was 4 cm. The
samples were then analyzed by 12% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE). The gels were
soaked in Enlightning Solution (PerkinElmer) and used for
fluorography [68].
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The gel shift assay provides a simple and rapid method for
detecting RNA-binding proteins. This method hasbeenwidely used
in the study of sequence-specific RNA-binding proteins. In this
assay, 1 mg of purified proteins and 4610
3 cpm of
32P-labeled RNA
substrates (m7G*pppA-RNA, m7G*pppG-RNA, m7G*pppA cap
analogue, and m7G*pppG cap analogue) were added to 20 mL
reaction mixtures [40 mM Tris-HCl (pH 7.5), 2 mM MgCl2,
2 mM DTT]. The reactions were incubated at room temperature
for 25 min, and separated by nondenaturing polyacrylamide gel (N-
PAGE). The RNA substrate bands were quantitated by scanning
the gels with a PhosphorImager.
RNA binding assay
In each set of RNA binding assay, 3 mg of freshly prepared
3H-
labeled RNA substrates (*m7GpppA-RNA, *m7GpppG-RNA,
*m7GpppA cap analogue, and *m7GpppG cap analogue) and
4 mg of purified His6-proteins were mixed in 100 mL binding
buffer [40 mM Tris-HCl (pH 7.5), 2 mM MgCl2]. The binding
reactions were shaken at 4uC over night. 20 mL high affinity Ni-
NTA resin (50% slurry, GenScript), equilibrated with binding
buffer, were added to binding reactions and mixed gently for
30 min at 4uC. The complex of
3H-labeled-RNA-His6 and Ni-
NTA-bound protein was pelleted by centrifugation for 20 s at
1000 g, and washed twice with binding buffer to remove free
3H-
labeled RNA substrates. The complex was finally resuspended in
100 mL of binding buffer, and a 30 mL aliquot was analyzed by
Western Blotting analysis with anti-His-tag antibody. The
remaining 70 mL was quantitated by liquid scintillation.
Isothermal Titration Calorimetry
ITC experiments on the interaction of SAM with nsp16, nsp10,
and nsp16/nsp10 complex of SARS-CoV in the absence of DTT
were carried out at 25uC using a VP-ITC titration calorimeter
(MicroCal, Northampton, MA). Freshly purified nsp16 and nsp10
proteins were mixed, and their final concentrations were 10 mM
and 80 mM, respectively. Then nsp16, nsp10, and nsp16/nsp10
complex were dialyzed against 40 mM Tris-HCl buffer (pH 8.0)
containing 50 mM NaCl, over night at 4uC, extensively to remove
glycerol and DTT. A solution of nsp16, nsp10, or nsp16/nsp10
complex was loaded into the sample cell (1.43 mL), and a solution
of 150 mM SAM was placed in the injection syringe (300 mL). The
first injection (5 mL) was followed by 29 injections of 10 mL.
Dilution heats of SAM were measured by injecting SAM solution
into buffer alone and were subtracted from the experimental
curves prior to data analysis.
The interaction of nsp16, nsp10, and nsp16/nsp10 complex of
SARS-CoV with m7GpppA-capped RNA in the absence of DTT
were carried out at 25uC using an ITC200 titration calorimeter
(MicroCal, Northampton, MA), which has higher sensitivity than
the equipment adopted for analyzing protein-SAM binding as
described above. A solution of m7GpppA-capped RNA (7 mM)
was loaded into the sample cell (500 mL), and a solution of 100 mM
purified proteins were placed in the injection syringe (40 mL).
Dilution heats of purified proteins were measured by injecting
purified proteins solution into buffer alone and were subtracted
from the experimental curves prior to data analysis.
The resulting data were fitted to a single set of identical sites
model using MicroCal ORIGIN software supplied with the
instrument, and the binding stoichiometry, N, the standard molar
enthalpy change for the binding, DbH0
m, and the dissociation
constant, Kd, were thus obtained. The standard molar free energy
change, DbG0
m, and the standard molar entropy change, DbS0
m, for
the binding reaction were calculated by the fundamental equations
of thermodynamics: DbG0
m =RTInKd; DbS0
m =(DbH0
m-DbG0
m)/T.
Accession numbers
The GenBank accession numbers for genes and proteins
mentioned in the text are as follow: SARS coronavirus nsp3
unique domain (SUD), JN247391; SARS coronavirus nonstruc-
tural protein nsp5, JN247392; SARS coronavirus nonstructural
protein nsp10, JN247393; SARS coronavirus nsp10-nsp11 fusion
protein, JN247394; SARS coronavirus nsp12 N-terminal domain
(nsp12N), JN247395; SARS coronavirus nonstructural protein
nsp14, JN247396; SARS coronavirus nonstructural protein nsp16,
JN247397.
Supporting Information
Figure S1 Comparison of the surface features between
nsp16/nsp10 and other 29-O MTases. (A) The SAM binding
cleft of nsp16 built by three loop regions. Nsp10 is show as ribbon
and colored in green. Nsp16 is shown as surface and colored in
cyan. Loop 71–79, loop 100–108 and loop 130–148 regions are
colored in yellow. SAM is shown as sticks and colored in magenta.
Comparison of the surfaces of nsp16/nsp10 (B), vaccinia virus
VP39 (PDB entry 1AV6) (C), Dengue virus NS5 MTase (PDB
entry 1L9K) (D), Escherichia coli FtsJ (PDB entry 1EJ0) (E) and
Bluetongue virus VP4 29-O-MTase (PDB entry 2JHP) (F). Proteins
are shown as surface and colored by secondary structure (a helix:
red, b strand: yellow, loop: green). SAM is shown as sticks and
colored by atoms (C: salmon, O: red, N: blue, H: white).
(TIF)
Figure S2 Structure-based sequence alignments of
nsp16 and nsp10. (A) Sequence alignment of representative
mRNA cap 29-O-MTases from vaccinia virus VP39 (PDB entry
1VPT), Flavivirus NS5 MTase (PDB entry 1L9K), and FtsJ (PDB
entry 1EIZ) with nsp16 of SARS-CoV. The secondary structure of
VP39 is shown above and that of nsp16 below the alignment.
Residues with 100% conservation are indicated in solid red boxes
and those with identity of 70% or higher are depicted in light red
color. Red arrowheads indicate the conserved K-D-K-E motif in
29-O-MTases. The short section of nsp16 aD helix as compared
with other 29-O-MTases and the flexible loop 130–148 of nsp16
are underlined in yellow. (B) Sequence and secondary structure of
coronavirus nsp10 from SARS-CoV, infectious bronchitis virus
(IBV), human coronavirus OC43 (HCoV-OC43), bovine corona-
virus (BcoV), murine hepatitis virus (MHV), transmissible
gastroenteritis virus (TGEV). The secondary structure of SARS-
CoV nsp10 is shown above.
(TIF)
Figure S3 K-D-K-E surface site in the central groove of
nsp16. Nsp16 is shown as surface with 20% transparency (A) and
ribbon (B). Lys-46, Asp-130, Lys-170 and Glu-203 are shown as
sticks and colored in magenta. Nsp10 is shown as ribbon and
colored in green. SAM is shown as sticks and colored in yellow.
The methyl group of SAM is colored in blue. Zinc ions are shown
as spheres.
(TIF)
Table S1 Primers used for PCR cloning of SARS-CoV
gene fragments into E. coli expression vector pET30a.
(DOC)
Table S2 X-ray crystallographic data and refinement
statistics for nsp16/nsp10/SAM complex.
(DOC)
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